CompletedNot applicableNCT06333691

Comparative Study Between Calcium Gluconate With Diosmin, Cabergoline and Cabergoline With Diosmin

Studying Ovarian hyperstimulation syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Minia University
Principal Investigator: Hatem Sarhan, Professor
Professor of Pharmaceutics, Faculty of Pharmacy, Minia University.
Intervention: Calcium Gluconate(drug)
Enrollment: 180 target
Eligibility: 23-39 years · FEMALE
Timeline: 2022 – 2024

Study locations (1)

Minia University, Faculty of Pharmacy, Minya, Egypt

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06333691 on ClinicalTrials.gov

Other trials for Ovarian hyperstimulation syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2NCT07043322
Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome
Tanta University

See all trials for Ovarian hyperstimulation syndrome →

← Back to all trials